Conflict of interest: FLD and BES have received research funding and honoraria from Therakos, a Johnson and Johnson company. The other authors have no conflict of interest to declare.
Letter to the Editor
A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors
Version of Record online: 6 DEC 2012
© 2012 John Wiley & Sons A/S
Volume 27, Issue 1, pages E1–E2, January–February 2013
How to Cite
Dignan, F. L., Manwani, R., Potter, M. N., Ethell, M. E., Leonard, H., Brennan, J., Baker, J. and Shaw, B. E. (2013), A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors. Clinical Transplantation, 27: E1–E2. doi: 10.1111/ctr.12051
- Issue online: 28 JAN 2013
- Version of Record online: 6 DEC 2012
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.